The Board of Directors of Novartis India Limited, at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 110.86 crore, against ₹101.43 crore in the corresponding quarter of the previous year (YoY) and ₹104.57 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹7.02 crore, against ₹7.52 crore in the corresponding quarter of the previous year (YoY) and ₹6.28 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹2.84, against ₹3.05 in the corresponding quarter of the previous year (YoY) and ₹2.55 in previous quarter (QoQ).
Total Income | ₹ 110.86 crs | ₹104.57 crs | 6.02% | ₹101.43 crs | 9.30% |
Net Profit | ₹7.02 crs | ₹6.28 crs | 11.78% | ₹7.52 crs | -6.65 % |
EPS | ₹2.84 | ₹2.55 | 11.37% | ₹3.05 | -6.89% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹215.43 crore, against ₹200.85 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹13.30 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹11.91 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹5.39 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹4.83 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹215.43 crs | ₹200.85 crs | 7.26% |
Net Profit | ₹13.30 crs | ₹11.91 crs | 11.67% |
EPS | ₹5.39 | ₹4.83 | 11.59% |
Shares of Novartis India Limited was last trading in BSE at Rs. 878.95 as compared to the previous close of Rs. 900.45. The total number of shares traded during the day was 36398 in over 2779 trades.
The stock hit an intraday high of Rs. 924.00 and intraday low of 855.65. The net turnover during the day was Rs. 32819457.00.
Source : Equity Bulls
Keywords
NovartisIndia
Q2FY22
H1FY22
ResultUpdate